The Medication Assisted Treatment Leadership Council is a healthcare trade association representing opioid treatment program facilities and practices. It lobbies Congress on expanding access to medication-assisted treatment for opioid use disorder and on Medicaid policy changes that affect coverage and payment for those services. Its filings show $200,000 spent across four reports, most recently in January 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAN ELLING
The latest disclosures for this client.
FEDERAL HEALTH POLICY STRATEGIES
Q2FEDERAL HEALTH POLICY STRATEGIES
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FEDERAL HEALTH POLICY STRATEGIES
FEDERAL HEALTH POLICY STRATEGIES
Q4FEDERAL HEALTH POLICY STRATEGIES
Q3FEDERAL HEALTH POLICY STRATEGIES
Q2FEDERAL HEALTH POLICY STRATEGIES
Q1